Tamoxifen-associated steatohepatitis--report of three cases
- PMID: 8530816
- DOI: 10.1016/0168-8278(95)80316-5
Tamoxifen-associated steatohepatitis--report of three cases
Abstract
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
